Atlas Trials

Hyperpolarized 13C Pyruvate MRI for Early Immune Evaluation in Cervical Cancer Patients At Baseline and CCRT Therapy

Clinical trial NCT04951921 · COMPLETED

Trial details

NCT number
NCT04951921
Sponsor
Chang Gung Memorial Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cervical Cancer
Start date
2021-07-15
Primary completion
2024-07-31
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.